Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study
Wissenschaftlicher Artikel
Fink, Anna Maria; Bahlo, Jasmin; Robrecht, Sandra; Al-Sawaf, Othman; Aldaoud, Ali; Hebart, Holger; Jentsch-Ullrich, Kathleen; Doerfel, Steffen; Fischer, Kirsten; Wendtner, Clemens-Martin; Noesslinger, Thomas; Ghia, Paolo; Bosch, Francesc; Kater, Arnon P.; Döhner, Hartmut; Kneba, Michael; Kreuzer, Karl-Anton; Tausch, Eugen; Stilgenbauer, Stephan; Ritgen, Matthias;
et al.
(Universität Ulm, 2017)
